Imperagen raises £5m to use quantum physics and artificial intelligence in enzyme engineering

Biotechnology company Imperagen announced A £5 million ($6.7 million) round led by PXN Ventures on Thursday, with participation from IQ Capital and Northern Gritstone. The company, in 2021, scientists from the Manchester Institute of Biotechnology Dr. Andrew Currin, Dr. Tim…












